A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation

International Journal of Molecular Sciences
Antonio VallarolaErmanno Gherardi

Abstract

Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease with no effective treatment. The Hepatocyte Growth Factor/Scatter Factor (HGF/SF), through its receptor MET, is one of the most potent survival-promoting factors for motor neurons (MN) and is known as a modulator of immune cell function. We recently developed a novel recombinant MET agonist optimized for therapy, designated K1K1. K1K1 was ten times more potent than HGF/SF in preventing MN loss in an in vitro model of ALS. Treatments with K1K1 delayed the onset of muscular impairment and reduced MN loss and skeletal muscle denervation of superoxide dismutase 1 G93A (SOD1G93A) mice. This effect was associated with increased levels of phospho-extracellular signal-related kinase (pERK) in the spinal cord and sciatic nerves and the activation of non-myelinating Schwann cells. Moreover, reduced activated microglia and astroglia, lower T cells infiltration and increased interleukin 4 (IL4) levels were found in the lumbar spinal cord of K1K1 treated mice. K1K1 treatment also prevented the infiltration of T cells in skeletal muscle of SOD1G93A mice. All these protective effects were lost on long-term treatment suggesting a mechanism of drug tolerance. These data pr...Continue Reading

References

Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·E GherardiR Furlong
Dec 13, 2005·Molecular and Cellular Neurosciences·Jenny S HenkelStanley H Appel
Mar 25, 2010·Proceedings of the National Academy of Sciences of the United States of America·Mahdia BenkhouchaPatrice H Lalive
Jul 25, 2013·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Weihua ZhaoStanley H Appel
Dec 7, 2013·Frontiers in Cellular Neuroscience·Melissa BowermanCédric Raoul
Dec 19, 2013·Journal of Neuroinflammation·Mahdia BenkhouchaPatrice H Lalive
Oct 27, 2014·International Immunology·Andrea MalaspinaSandra Amor
Dec 6, 2014·Autoimmunity Reviews·Nicolas MolnarfiPatrice H Lalive
Jan 7, 2016·Stroke; a Journal of Cerebral Circulation·Xiangrong LiuXiaoming Hu
Feb 7, 2017·Nature Reviews. Immunology·James G Tidball
Feb 9, 2017·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Robert L SufitJohn A Kessler
Jul 13, 2017·The New England Journal of Medicine·Robert H Brown, Ammar Al-Chalabi
Mar 3, 2018·Journal of Neuroinflammation·Antonio VallarolaCaterina Bendotti
Aug 11, 2018·Molecular Neurodegeneration·Giovanni NardoCaterina Bendotti
Jan 22, 2019·Lancet Neurology·David R Beers, Stanley H Appel
Jan 25, 2019·Proceedings of the National Academy of Sciences of the United States of America·Emmanuelle CoqueCédric Raoul
Dec 24, 2019·Frontiers in Neuroscience·Rita MejziniP Anthony Akkari

❮ Previous
Next ❯

Citations

Jun 29, 2021·Frontiers in Cell and Developmental Biology·Claudia DesoleTiziana Crepaldi

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
gel filtration
FCS
Thermal shift
confocal microscopy
PCR

Software Mentioned

ImageLab
ImageJ
Excel
Prism

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.